Hannah Valantine

Hannah Valantine

Director/Board Member at CAREDX, INC.

Net worth: 2 M $ as of 30/06/2026

74 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Hannah A. Valantine, MD, is an Independent Director at BridgeBio Pharma, Inc., an Independent Director at CareDx, Inc., an Independent Director at Pacific Biosciences of California, Inc., a Principal at Hav LLC, a Professor at Stanford University School of Medicine and a Member at National Academy of Medicine (United States).
She is on the Board of Directors at BridgeBio Pharma, Inc., CareDx, Inc. and Pacific Biosciences of California, Inc. She received her undergraduate degree from the University of London and a doctorate degree from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/07/2026 36,686 ( 0.07% ) 1 M $ 30/06/2026
23/06/2026 9,657 ( 0% ) 719 253 $ 30/06/2026
03/06/2026 22,821 ( 0.01% ) 38 339 $ 30/06/2026

Hannah Valantine active positions

CompaniesPositionStart
CAREDX, INC. Director/Board Member 01/07/2021
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director/Board Member 16/06/2021
BRIDGEBIO PHARMA, INC. Director/Board Member 23/10/2021
Corporate Officer/Principal 01/01/1987
Hav LLC
Founder 01/01/2021
Corporate Officer/Principal -

Training of Hannah Valantine

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Hav LLC

  1. Stock Market
  2. Insiders
  3. Hannah Valantine